UFP Technologies, Inc.

NASDAQ:UFPT

Medical - Devices

Healthcare
$305.65 +4.44%

+$10.10 today

Market cap
$2.37B
Beta
1.10
P/E (TTM)
26.8
EPS (TTM)
$8.89
52W Low $173.86High $274.93

Volume 0.08M

Average 0.21M

UFPT Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

UFP Technologies, Inc.NASDAQ: UFPT

Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026

Cost of revenue growth accelerates

Q2 FY2026 cost of revenue of $123.05M rose 14.3% year over year, ahead of the +7.7% change in trailing-twelve-month cost of revenue. Sequentially, it rose 12.0% from the prior quarter. Over 3 fiscal years it compounded at +17.9% a year.

Context

  • Cost of revenue amounted to 71.7% of revenue in FY2025, up 0.8 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +14.3% holds above the trailing-twelve-month pace of +7.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$123.05M+12.0% QoQ
Last fiscal yearDec 2025
$432.39M+20.9% YoY
LTMJun 2026
$451.64M+7.7% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+14.3%——
1 year+20.9%——
3-year CAGR+17.9%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
432.39M USD
Year-over-year change
+20.9%
4-year CAGR
+29.2%

Cost of Revenue vs competitors

How UFPT compares with its peers on the latest reported figures

  • UFPT's LTM Jun 2026 cost of revenue of $451.64M is the 6th highest of the 11 companies compared; the peer median is $357.81M.
  • Its year-over-year change of +7.7% is the 6th highest of 11, against a peer median of +7.0%.
  • Cost of revenue amounts to 71.5% of revenue for UFPT, versus a peer median of 38.2%.
UFPT Competitors Peer median
Cost of Revenue for UFPT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$12.51B +0.0%+5.9%33.3%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$11.56B -1.0%+3.5%57.1%
ENOVEnovis CorporationLTM Apr 2026$983.94M +5.2%+9.2%43.2%
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026$769.47M +2.0%+10.4%46.8%
CNMDCONMED CorporationLTM Mar 2026$636.88M +8.8%+11.0%46.4%
UFPTUFP Technologies, Inc.LTM Jun 2026$451.64M +7.7%+17.9%71.5%
ESTAEstablishment Labs Holdings Inc.LTM Sep 2026$78.74M +31.9%+5.5%29.8%
KIDSOrthoPediatrics Corp.LTM Mar 2026$65.51M +13.4%+26.3%26.9%
SIBNSI-BONE, Inc.LTM Mar 2026$42.1M +14.9%+37.7%20.4%
RXSTRxSight, Inc.LTM Mar 2026$29.3M -43.5%+4.4%23.0%
SSIISS Innovations International, Inc.LTM Mar 2026$25M +102.6%+187.2%51.6%
Peer median (excluding UFPT) $357.81M+7.0%+9.8%38.2%

Competitors are the stored peer set for UFPT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue206.32M353.79M400.07M504.42M602.8M
Cost of Revenue155.21M263.53M287.85M357.73M432.39M
Gross Profit51.11M90.26M112.23M146.69M170.41M
Gross Margin24.8%25.5%28.1%29.1%28.3%
Research & Development00000
Selling, General & Admin29.48M45.8M50.89M62.22M77.44M
Operating Expenses29.9M34.86M54.56M65.8M78.07M
Depreciation & Amortization8.41M11.89M11.41M14.72M19.15M
EBITDA29.65M67.37M68.95M95.8M111.47M
EBITDA Margin14.4%19.0%17.2%19.0%18.5%
Operating Income21.22M55.4M57.66M80.9M92.34M
Operating Margin10.3%15.7%14.4%16.0%15.3%
Interest Income49K0000
Interest Expense39K2.76M3.65M8.06M9.8M
Other Income / Expenses(13K)(2.68M)(3.76M)(7.87M)(9.83M)
Income Before Tax21.21M52.72M53.9M73.03M82.51M
Pre-Tax Margin10.3%14.9%13.5%14.5%13.7%
Income Tax Expense5.32M10.93M8.98M14.04M14.2M
Net Income15.89M41.79M44.92M58.98M68.31M
Net Margin7.7%11.8%11.2%11.7%11.3%
EPS (Basic)2.115.525.897.698.87
EPS (Diluted)2.095.455.837.588.77
Weighted Avg Shares7.52M7.56M7.62M7.67M7.71M
Weighted Avg Shares (Diluted)7.62M7.66M7.7M7.79M7.8M

UFP Technologies, Inc.

NASDAQ:UFPT

Intrinsic Alpha fair value

Locked

Current Price

$305.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.